We are live on ! Find out more
AHPI

Allied Healthcare Products

Delisted

AHPI was delisted on the 2nd of February, 2023.

10 hedge funds and large institutions have $1.26M invested in Allied Healthcare Products in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more capital invested

Capital invested by funds: $829K → $1.26M (+$434K)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

11% more funds holding

Funds holding: 910 (+1)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AHPI Hedge Fund Activity: Q2 2017 in Review

10 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q2 2017, worth a combined $1.26M — up 52% from $829K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AHPI positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $76K. The largest seller was Goldman Sachs, exiting entirely with an estimated $26K sold.

  • 10 institutional investors held Allied Healthcare Products (AHPI) as of Q2 2017, up from 9 in Q1 2017.
  • Funds reported $1.26M of Allied Healthcare Products stock for Q2 2017, up 52% quarter-over-quarter.
  • 3 funds opened new Allied Healthcare Products positions in Q2 2017 and 2 closed out, a net change of +1 holder.
  • The largest Allied Healthcare Products buyer in Q2 2017 was Virtu KCG Holdings, an estimated $76K added.
  • The largest Allied Healthcare Products seller in Q2 2017 was Goldman Sachs, an estimated $26K sold.

Based on aggregated 13F filings for Q2 2017.